Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 14 Prostatic Neoplasms 9 Leukemia, Myeloid, Acute 9 Endometrial Neoplasms 8 Breast Neoplasms 7 Oropharyngeal Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Lung Neoplasms 5 Colonic Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Multiple Myeloma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia, Erythroblastic, Acute 4 Congenital Abnormalities 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Rectal Neoplasms 3 Neuroblastoma 3 Mouth Neoplasms 3 Lymphoma, Follicular 3 Leukemia 3 Esophageal Neoplasms 3 Brain Neoplasms 3

Interventions

Gemcitabine 13 pembrolizumab 9 Specimen Handling 9 enfortumab vedotin 8 Cisplatin 8 Magnetic Resonance Spectroscopy 7 avelumab 5 Carboplatin 5 vinflunine 4 Nivolumab 4 atezolizumab 3 Immunoglobulin G 3 Disulfides 3 Biopsy 3 eribulin 2 cabozantinib 2 Standard of Care 2 Ramucirumab 2 Radiotherapy 2 Platinum 2 Nephroureterectomy 2 Ipilimumab 2 Doxorubicin 2 Docetaxel 2 CTLA-4 Antigen 2 Bortezomib 2 1,2-diaminocyclohexaneplatinum II citrate 2 vandetanib 1 tremelimumab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ureteral Neoplasms × Observation × Clear all

NCT03244384 2026-05-29

AMBASSADOR

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡